Multibic

Sodium hydrogen carbonate, the active ingredient in Multibic, is an electrolyte solution presented as an intravenous solution for haemodialysis use. It provides buffering capacity and essential electrolytes to support acid‑base balance and osmotic stability in patients undergoing renal replacement therapy.

GNH USA supplies Multibic as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres and dialysis clinics worldwide. The company adheres to stringent quality standards and provides regulatory support for global distribution. Customers benefit from reliable supply chains, comprehensive documentation, and responsive technical assistance.

Multibic is used in the electrolyte management pathway for patients undergoing haemodialysis.

Hemodialysis: provides sodium, potassium, magnesium, chloride and bicarbonate to maintain electrolyte equilibrium and buffering capacity during each dialysis session. Acute kidney injury requiring renal replacement therapy: delivers essential ions to support acid‑base balance and prevent rapid shifts in plasma electrolytes. Chronic kidney disease patients on maintenance dialysis: helps stabilize serum electrolyte concentrations and reduces the risk of metabolic alkalosis over long‑term treatment.

Multibic may be associated with infusion‑related adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Mild hypernatremia: slight increase in serum sodium levels. - Mild hyperkalemia: transient elevation of potassium. - Nausea: occasional feeling of queasiness during infusion. - Infusion site irritation: redness or discomfort at the catheter site.

Serious or Rare Side Effects: - Severe hyperkalemia: marked potassium rise leading to cardiac arrhythmia. - Metabolic alkalosis: excessive bicarbonate causing pH elevation. - Anaphylactoid reaction: rare hypersensitivity with hypotension and rash.

When using Multibic, clinicians should observe specific precautions to ensure patient safety and product integrity. - Assess baseline electrolyte and acid‑base status: obtain serum labs before infusion. - Monitor blood pressure and cardiac rhythm during administration: watch for hypotension or arrhythmias. - Adjust composition for patients with cardiac disease or fluid overload: tailor electrolyte concentrations as needed. - Avoid use in patients with severe hyperkalemia: risk of dangerous potassium accumulation. - Use aseptic technique for preparation and connection: prevent contamination. - Store at ambient temperature: keep in original container, protect from moisture and direct sunlight.

Multibic can interact with other medications or solutions that affect electrolyte balance or acid‑base status.

Major Interactions (Avoid): - Concurrent potassium‑sparing diuretics: may cause dangerous hyperkalemia. - High‑dose sodium bicarbonate therapy: risk of severe metabolic alkalosis. - Calcium‑containing intravenous solutions: potential calcium overload and precipitation.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: monitor serum potassium levels closely. - Beta‑blockers: observe for additive blood pressure effects. - Other intravenous electrolyte preparations: adjust dosing to avoid excess ions.